ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

191
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
24 Mar 2017 16:32

Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas

This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...

Share
25 Oct 2016 12:40

Key Drivers of Asia's Healthcare Sector

From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...

Share
bullishJacobson Pharma
13 Sep 2016 12:23

Jacobson Pharma IPO -- Home Team Advantage

Jacobson Pharmaceutical Corporation Limited is a pending listing on the HKEX. This Insight forks Toh Zhen Zhou 's Insight Jacobson Pharma IPO -...

Share
bullish3SBio Inc
27 Jan 2016 10:48

China's FDA Ups Its Game

One of the pharmaceutical industry’s main complaints about China is the extremely slow drug approval process. The approval process in China...

Share
16 Dec 2015 16:22

HEC ChangJiang Pharma IPO - Just a Manufacturing Shell

YiChang HEC ChangJiang Pharmaceuticals (YHCP) plans to raise US$160-215m through an issuance of primary shares in its IPO.We've worked along...

Logo
380 Views
Share
x